Skip to results
Modify your search
NARROW
1-20 of 54
Authors: Helio S. Sader
Journal Article
7-Year (2015–21) longitudinal surveillance of lefamulin in vitro activity against bacterial pathogens collected worldwide from patients with respiratory tract infections including pneumonia and characterization of resistance mechanisms
Journal of Antimicrobial Chemotherapy, Volume 79, Issue 2, February 2024, Pages 360–369, https://doi.org/10.1093/jac/dkad389
Published: 19 December 2023
Journal Article
Antimicrobial activity of cefepime/zidebactam (WCK 5222), a β-lactam/β-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018–19)
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 10, October 2022, Pages 2642–2649, https://doi.org/10.1093/jac/dkac233
Published: 28 July 2022
Journal Article
Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolates
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 12, December 2021, Pages 3125–3134, https://doi.org/10.1093/jac/dkab306
Published: 30 August 2021
Journal Article
Investigation of mechanisms responsible for decreased susceptibility of aztreonam/avibactam activity in clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 11, November 2021, Pages 2833–2838, https://doi.org/10.1093/jac/dkab279
Published: 26 August 2021
Journal Article
Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 3, March 2021, Pages 659–666, https://doi.org/10.1093/jac/dkaa504
Published: 04 December 2020
Journal Article
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against European Gram-negative bacterial surveillance isolates collected during 2012–18
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 10, October 2020, Pages 2907–2913, https://doi.org/10.1093/jac/dkaa278
Published: 10 July 2020
Journal Article
Antimicrobial activity of POL7306 tested against clinical isolates of Gram-negative bacteria collected worldwide
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 6, June 2020, Pages 1518–1524, https://doi.org/10.1093/jac/dkaa020
Published: 22 February 2020
Journal Article
Combination of MexAB-OprM overexpression and mutations in efflux regulators, PBPs and chaperone proteins is responsible for ceftazidime/avibactam resistance in Pseudomonas aeruginosa clinical isolates from US hospitals
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 9, September 2019, Pages 2588–2595, https://doi.org/10.1093/jac/dkz243
Published: 21 June 2019
Journal Article
Pharmacokinetic/pharmacodynamic target attainment analyses to support intravenous and oral lefamulin dose selection for the treatment of patients with community-acquired bacterial pneumonia
Journal of Antimicrobial Chemotherapy, Volume 74, Issue Supplement_3, April 2019, Pages iii35–iii41, https://doi.org/10.1093/jac/dkz089
Published: 05 April 2019
Journal Article
Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA and Europe (2014–17)
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 7, July 2019, Pages 1928–1933, https://doi.org/10.1093/jac/dkz120
Published: 01 April 2019
Journal Article
Geographical and temporal variation in the frequency and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bacterial pneumonia: results from 20 years of the SENTRY Antimicrobial Surveillance Program (1997–2016)
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 6, June 2019, Pages 1595–1606, https://doi.org/10.1093/jac/dkz074
Published: 06 March 2019
Journal Article
Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1306–1310, https://doi.org/10.1093/jac/dkz006
Published: 07 February 2019
Journal Article
Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015–17)
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 11, November 2018, Pages 3053–3059, https://doi.org/10.1093/jac/dky279
Published: 27 July 2018
Journal Article
Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015–16
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 10, October 2018, Pages 2748–2756, https://doi.org/10.1093/jac/dky235
Published: 29 June 2018
Journal Article
Murepavadin activity tested against contemporary (2016–17) clinical isolates of XDR Pseudomonas aeruginosa
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 9, September 2018, Pages 2400–2404, https://doi.org/10.1093/jac/dky227
Published: 12 June 2018
Journal Article
ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 7, July 2018, Pages 1880–1887, https://doi.org/10.1093/jac/dky099
Published: 06 April 2018
Journal Article
Antimicrobial activity of oritavancin and comparator agents when tested against Gram-positive bacterial isolates causing infections in cancer patients (2014–16)
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 4, April 2018, Pages 916–922, https://doi.org/10.1093/jac/dkx485
Published: 25 December 2017
Journal Article
EDITOR'S CHOICE
WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 6, June 2017, Pages 1696–1703, https://doi.org/10.1093/jac/dkx050
Published: 18 March 2017
Journal Article
Longitudinal (2001–14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010–13) analysis of oritavancin in vitro potency
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 12, 1 December 2016, Pages 3453–3458, https://doi.org/10.1093/jac/dkw319
Published: 08 September 2016
Journal Article
Surveillance for linezolid resistance via the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility rates
Journal of Antimicrobial Chemotherapy, Volume 71, Issue 7, July 2016, Pages 1860–1865, https://doi.org/10.1093/jac/dkw052
Published: 23 March 2016
